Soligenix
SNGX
#10276
Rank
HK$98.49 M
Marketcap
HK$9.77
Share price
-4.58%
Change (1 day)
-46.23%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2025 (TTM): -HK$96.37 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -HK$73.04 Million a decrease over its 2023 earnings that were of -HK$59.4 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$96.37 Million31.95%
2024 -HK$73.04 Million22.96%
2023 -HK$59.4 Million-45.74%
2022 -HK$0.11 Billion11.88%
2021 -HK$97.83 Million-32.37%
2020 -HK$0.15 Billion83.18%
2019 -HK$78.97 Million11.57%
2018 -HK$70.78 Million19.29%
2017 -HK$59.33 Million33%
2016 -HK$44.61 Million-19.7%
2015 -HK$55.56 Million5.16%
2014 -HK$52.83 Million
2010 -HK$59.63 Million26.12%
2009 -HK$47.28 Million75.1%
2008 -HK$27 Million-45.38%
2007 -HK$49.44 Million-22.84%
2006 -HK$64.07 Million66.15%
2005 -HK$38.56 Million-16.65%
2004 -HK$46.26 Million13.28%
2003 -HK$40.84 Million-11.88%
2002 -HK$46.35 Million-59.44%
2001 -HK$0.12 Billion378.18%
2000 -HK$23.9 Million-38.53%
1999 -HK$38.88 Million-18.43%
1998 -HK$47.66 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$253.10 B-262,014.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$92.59 B-95,920.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$71.09 B-73,673.72%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-HK$0.15 Billion 46.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-HK$0.33 Billion 237.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$13.84 B-14,426.25%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-HK$21.51 Million-77.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$1.29 B-1,436.42%๐Ÿ‡บ๐Ÿ‡ธ USA